VIR | Vir Biotechnology Inc
Category: Consumer goods
Quick infos Headquarters: San Francisco, California, United States Trade prices Volume: Market Cap: 4.73B Prev closed: 42.97 Open: 42.1 High: 42.2 Low: 38.44 52 week low: 25.31 52 week high: 141.01 Dividends: No Dividends Next ER: August 5, 2021 After Market Closes
Earnings History Date EPS / Forecast Revenue / Forecast November 16, 2021 August 5, 2021 0.46 / -0.4771177.07M / 84.56MBeat! May 6, 2021 -1.32 / -0.21291.98M / 98.64MFebruary 25, 2021 -0.83 / -0.70321.73M / 4.81MNovember 10, 2020 -0.67 / -0.59751.93M / 11.01Mview more
Historical Data Date Price Open High Low Vol Change ER Sep 17, 2021 54.54 52.67 54.59
51.98
1.02M 3.67% Sep 16, 2021 52.61 51.77 53.43
51.45
795.82K 0.57% Sep 15, 2021 52.31 50.04 53.55
49.00
1.21M 4.27% Sep 14, 2021 50.17 50.02 54.38
49.97
1.23M 0.60% Sep 13, 2021 49.87 51.00 51.53
48.96
728.91K -3.54% Sep 10, 2021 51.70 51.33 52.38
50.00
876.74K 4.42% Sep 9, 2021 49.51 48.67 50.30
48.51
392.59K 1.12% Sep 8, 2021 48.96 49.27 49.94
47.84
427.80K -1.45% Sep 7, 2021 49.68 49.00 51.08
48.85
575.45K 1.47% Sep 3, 2021 48.96 50.00 50.00
48.34
417.15K -1.37% view more
NASDAQ - Nasdaq Stock Market
News
U.S. FDA gives emergency use approval for GSK-Vir COVID-19 antibody drug finance.yahoo.com Sep 22, 2021 5:55 pm
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2021 Financial Results finance.yahoo.com Sep 22, 2021 4:05 pm
Vir Biotech's HBV Candidates Show Positive Safety Profiles finance.yahoo.com Sep 22, 2021 3:02 pm
Why Vir Biotechnology Stock Is Higher Today fool.com Sep 22, 2021 1:00 pm
Why Vir Biotechnology Stock Is Dropping Today fool.com Sep 22, 2021 12:55 pm
Why Vir Biotechnology Stock Is Falling Today fool.com Sep 22, 2021 12:52 pm UPDATE 2-EMA starts review of GSK's monoclonal antibody to treat COVID-19 patients finance.yahoo.com Sep 22, 2021 8:59 am Europe buys 220,000 doses of Vir, GSK's experimental COVID-19 treatment marketwatch.com Sep 22, 2021 8:51 am GlaxoSmithKline and Vir Biotech seek FDA emergency authorization for COVID antibody treatment marketwatch.com Sep 22, 2021 8:40 am
Virs Covid-19 Antibody Works Well, Sending Shares Flying barrons.com Sep 22, 2021 8:38 am
Are Options Traders Betting on a Big Move in Vir Biotechnology (VIR) Stock? finance.yahoo.com Sep 22, 2021 8:35 am
Lilly, Vir Biotechnology and GSK Announce Positive Topline Data from the Phase 2 BLAZE-4 Trial Evaluating Bamlanivimab with VIR-7831 in Low-Risk Adults with COVID-19 finance.yahoo.com Sep 22, 2021 8:30 am
Vir Biotechnology Initiates Phase 2 Clinical Trial Evaluating the Combination of VIR-2218 and VIR-3434 as a Functional Cure Regimen for Chronic Hepatitis B Virus Infection finance.yahoo.com Sep 22, 2021 8:30 am
Vir Biotechnology, Inc. (VIR) Surges 32.1%: Is This an Indication of Further Gains? finance.yahoo.com Sep 22, 2021 8:04 am
Brii Biosciences, Vir Biotechnology, and VBI Vaccines Announce Initiation of Phase 2 Clinical Trial of BRII-835 (VIR-2218) in Combination with BRII-179 (VBI-2601) for the Treatment of Hepatitis B finance.yahoo.com Sep 22, 2021 8:00 am NIH stops clinical trials for two experimental antibody COVID-19 treatments marketwatch.com Sep 22, 2021 7:54 am
What's in the Cards for Eli Lilly (LLY) This Earnings Season? finance.yahoo.com Sep 22, 2021 6:52 am
Vir Biotech Soars as Covid Therapy Found Effective at Cutting Deaths finance.yahoo.com Sep 22, 2021 6:45 am
Can Vir Biotechnology Distinguish Itself In The Vaccine Market? finance.yahoo.com Sep 22, 2021 6:35 am
Calculating The Fair Value Of Vir Biotechnology, Inc. (NASDAQ:VIR) finance.yahoo.com Jul 21, 2021 8:06 am This company doesn't provide a dividend.
Key Persons Talk about Vir Biotechnology Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.
A simple, straightforward guide to the fundamentals of technical analysis
